GLP-1 and incretin research peptides — including semaglutide, tirzepatide, cagrilintide and the triple agonist retatrutide — studied in laboratory research for glucose-dependent insulin signalling, appetite pathways and energy metabolism.
Incretin-class compounds differ mainly in receptor coverage. Single agonists act at the GLP-1 receptor; dual agonists add GIP or glucagon receptor activity; retatrutide is a triple agonist covering all three. Molecular weights in this class are comparatively large, and vials are correspondingly light — which is why the assay figure on a certificate matters more here than in most classes.
2 of the 13 compounds in this category have a published third-party certificate — purity, assay mass, batch number and test date are on the CoA library.
Every compound is supplied at ≥98% HPLC purity, batch-traceable, and tested by Janoshik Analytical — an independent third-party laboratory. Pricing is in AUD, payment by PayID, and orders ship tracked via Australia Post to every state. See buy peptides Australia for delivery detail, or work out concentrations with the reconstitution calculator.
All materials on this page are supplied strictly For Research Use Only — not for human or veterinary use or consumption.